Evolus (EOLS)

Evolus (NASDAQ:EOLS – Get Free Report) is expected to be releasing its Q1 2025 earnings data after the market closes on Wednesday, May 7th. Analysts expect the company to announce earnings of ($0.04)… [+3247 chars]...

Price T Rowe Associates Inc. MD increased its stake in Evolus, Inc. (NASDAQ:EOLS – Free Report) by 13.7% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 52,593 s… [+4718 chars]...

Needham & Company LLC reaffirmed their buy rating on shares of Evolus (NASDAQ:EOLS – Free Report) in a research report sent to investors on Thursday morning,Benzinga reports. Needham & Compan… [+4460 chars]...

BNP Paribas Financial Markets cut its stake in shares of Evolus, Inc. (NASDAQ:EOLS – Free Report) by 42.3% during the 4th quarter, Holdings Channel reports. The fund owned 36,213 shares of the compan… [+4938 chars]...

Raymond James Financial Inc. purchased a new position in shares of Evolus, Inc. (NASDAQ:EOLS – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exc… [+4982 chars]...

Invesco Ltd. reduced its position in Evolus, Inc. (NASDAQ:EOLS – Free Report) by 81.9% in the 4th quarter, HoldingsChannel.com reports. The fund owned 18,326 shares of the company’s stock after selli… [+4851 chars]...